Chemosensitivity study of urological malignancies using a novel dye-exclusion method Katsusuke Naitoharuo HisazumiTadao Uchibayashi The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S1 - S5
Intra-arterial chemotherapy for bladder cancer Shori KanohRyosuke NoguchiRyuichi Kitagawa The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S6 - S9
The role of preoperative intra-arterial doxorubicin chemotherapy in combination with low-dose irradiation for bladder cancer Takeshi UyamaShoosuke MoriwakiJiro Fujita The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S10 - S14
Preoperative one-shot intra-arterial infusion chemotherapy for bladder cancer Hiroshi KakizakiHitoshi SuzukiKiichi Suzuki The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S15 - S19
Three-drug combination chemotherapy for advanced urothelial tract carcinoma Shinichi OhshimaYoshinari OnoYoshio Aso The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S20 - S23
Adjuvant chemotherapy for invasive bladder cancer Yasunari UekadoToshiaki ShinkaTadashi Ohkawa The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S24 - S28
Adjuvant chemotherapy for uroepithelial transitional cell carcinoma Manabu KuriyamaToshimi TakeuchiTsuneo Nishiura The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S29 - S33
Postoperative systemic adjuvant chemotherapy for bladder cancer Hisakazu KiyoharaMasao KurodaToshihiko Kotake The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S34 - S38
The chemotherapy of advanced bladder cancer Donald W. W. NewlingGerrit StoterMembers of the EORTC GU Tract Cooperative Group The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S39 - S43
Phase III trial of The Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder Akio MaruHideyuki AkazaThe Japanese Urological Cancer Research Group for Adriamycin The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S44 - S48
Size and location of tumors influencing the effect of bladder instillation therapy Hiroki WatanabeMasahiro NakaoHitoshi Takada The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S49 - S51
Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors Iwao FukuiHideaki SekineHiroyuki Oshima The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S52 - S55
Preoperative doxorubicin instillation in recurrent superficial bladder cancer Yoshinobu KubotaSumio NoguchiShuji Fukushima The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S56 - S59
Intravesical chemotherapy Tsuneaki ObamaYosuke MatsumuraOkayama Urological Cancer Collaborative Group (OUCCG) The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S60 - S62
Approaches to the treatment of bladder cancer at Stanford Frank M. Torti The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S63 - S66
Current status of intravesical chemotherapy trials in the EORTC Urological Group. An Overview L. DenisC. BouffiouxMembers of the EORTC Urological Group The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S67 - S71
Prophylactic intravesical instillation therapy with adriamycin and mitomycin C in patients with superficial bladder cancer Tomoyasu TsushimaYosuke MatsumuraOkayama Urological Cancer Collaborating Group (OUCCG) The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S72 - S76
Prophylaxis of superficial bladder cancer with instillation of adriamycin or mitomycin C Shigeo IsakaTatsuya OkanoYutaka Kitamura The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S77 - S80
Early intravesical instillation of adriamycin with oral administration of 5-fluorouracil after transurethral resection for superficial bladder cancer: preliminary results Toyofumi UedaAtsushi IguchiThe Kyushu University Urological Oncology Group The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S81 - S84
Prophylactic treatment for superficial bladder cancer following transurethral resection Yoshihiko HiraoEigoro OkajimaShuji Watanabe The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S85 - S90
Comparative analysis of short-term and long-term prophylactic intravesical chemotherapy of superficial bladder cancer Hideyuki AkazaShigeo IsakaThe Japanese Urological Cancer Research Group for Adriamycin The Third International Conference on Treatment of Urinary Tract Tumors with Adriamycin September 26–27, 1986-Tokyo Pages: S91 - S96